Milan Zdravkovic
Founder at Selma Diagnostics ApS
Profile
Milan Zdravkovic is the founder of Selma Diagnostics ApS, which was founded in 2016.
He is currently a Director at Empros Pharma AB since 2020.
Dr. Zdravkovic has held former positions as Director at Pila Pharma AB, Vice President at Novo Nordisk Scandinavia AB from 1998 to 2007, and Chief Medical Officer and Head of Research & Development at Swedish Orphan Biovitrum AB from 2016 to 2020.
Dr. Zdravkovic has a doctorate degree from the University of Aarhus in 1996 and another doctorate degree from the same university in 2000.
He also has a graduate degree from the University of Surrey in 2007.
Milan Zdravkovic active positions
| Companies | Position | Start |
|---|---|---|
| Selma Diagnostics ApS | Founder | 2016-04-30 |
Empros Pharma AB
 Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Director/Board Member | 2019-12-31 |
Former positions of Milan Zdravkovic
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2020-08-17 |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Corporate Officer/Principal | 2006-12-31 |
| PILA PHARMA AB | Director/Board Member | - |
Training of Milan Zdravkovic
| University of Aarhus | Doctorate Degree |
| University of Surrey | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| PILA PHARMA AB | Health Technology |
| Private companies | 3 |
|---|---|
Novo Nordisk Scandinavia AB
Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Health Technology |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Health Technology |
| Selma Diagnostics ApS |
- Stock Market
- Insiders
- Milan Zdravkovic
